Inventor · disambiguated record

Nicholas Mccartney Plugis

Also filed as: PLUGIS NICHOLAS MCCARTNEY

11 granted patents·36 pending applications·59 citations·filing 2018–2025

88Inventor score

Technology areasC12N A61K C12P A61P G16B

Files withFLAGSHIP PIONEERING INNOVATIONS VI LLC39 FLAGSHIP PIONEERING INNOVATIONS V INC4 FLAGSHIP PIONEERING INNOVATIONS VII LLC3 FLAGSHIP PIONEERING INC1

Top patents by PatentIndex Score

47 records

0196US11458156B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Oct 4, 2022·10 cites·30 claims
0296US11160822B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Nov 2, 2021·10 cites·30 claims
0396US11058706B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Jul 13, 2021·17 cites·30 claims
0496US10953033B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2019·Granted Mar 23, 2021·19 cites·36 claims
0595US11844759B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Granted Dec 19, 2023·2 cites·30 claims
0688US2024122959A1Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
0787US12357653B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2018·Granted Jul 15, 2025·1 cites·16 claims
0887US2025381211A1Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
0983US2025059511A1Systems and methods for associating compounds with physiological conditions using fingerprint analysisFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Application pending·0 cites
1078US12374430B2Systems and methods for associating compounds with properties using clique analysis of cell-based dataFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Granted Jul 29, 2025·0 cites·29 claims
1176US11978538B2Systems and methods for associating compounds with properties using clique analysis of cell-based dataFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Granted May 7, 2024·0 cites·24 claims
1275US2023279423A1Compositions comprising curons and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
1374US12060578B2Systems and methods for associating compounds with physiological conditions using fingerprint analysisFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Granted Aug 13, 2024·0 cites·30 claims
1471US12282499B1Database processing system for determining whether an entity affects a transitionFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Apr 22, 2025·0 cites·15 claims
1567US2023061936A1Methods of dosing circular polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
1666US2019211361A1Compositions comprising curons and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
1766US2023203158A1Methods for modulating intestine cells or tissue functionFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2022·Application pending·0 cites
1864US2025051386A1Compositions and methods for purifying polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
1963US2020385757A1Compositions comprising curons and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
2063US2020123203A1Compositions comprising curons and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2018·Application pending·0 cites
2162US2025353906A1Compositions and methods for targeted delivery of therapeutic agentsFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2023·Application pending·0 cites
2261US2023083717A1Methods and compositions for promoting adipocyte beigingFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
2361US2024401024A1Methods for enrichment of circular rna under denaturing conditionsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
2460US12480117B2Compositions comprising modified circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Granted Nov 25, 2025·0 cites·12 claims
2560US2022399129A1Systems and methods for terraformingFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
2660US2024360411A1Methods and compositions for inducing fetal hemoglobin, modulating erythroid cell lineages, and perturbing megakaryocyte lineagesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
2757US2024424022A1In vivo and ex vivo methods of modulating t cell exhaustion/de-exhaustionFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
2857US2024374592A1Methods and compositions for perturbing monocyte and neutrophil lineagesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
2956US2024009298A1Immunogenic compositions and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
3056US2025163151A1Methods for modulating intestine cells or tissue functionFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2025·Application pending·0 cites
3156US2023077584A1Methods and compositions for modulating enteroendocrine cellsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
3256US2022296729A1Methods of dosing circular polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
3355US2020020419A1Methods of analyzing cellsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2019·Application pending·0 cites
3454US2023181722A1Coronavirus antigen compositions and their usesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
3554US2023193311A1Immunogenic compositions and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
3653US2024361301A1Methods and compositions for modulating goblet cells and for muco-obstructive diseasesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
3753US2022143062A1Circular polyribonucleotides and pharmaceutical compositions thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
3853US2023104113A1Delivery of compositions comprising circular polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
3953US2023181620A1Compositions for translation and methods of use thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
4051US2023203192A1Compositions and methods for producing human polyclonal antibodiesFLAGSHIP PIONEERING INC·Filed 2021·Application pending·0 cites
4151US2022142896A1Polyribonucleotides and cosmetic uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
4251US2023144855A1Methods and compositions for inducing fetal hemoglobinFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
4351US2022257794A1Circular rnas for cellular therapyFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
4450US2021292761A1Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2019·Application pending·0 cites
4549US2022088049A1Compositions, methods, and kits for delivery of polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
4649US2022305128A1Compositions comprising circular polyribonucleotides for protein modulation and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
4748US2023052677A1Molecule designFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Nicholas Mccartney Plugis files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →